# Bluesight

> Bluesight sells hospital pharmacy and compliance software covering medication inventory, diversion surveillance, purchasing, 340B auditing, shortages, and patient privacy. Founded as Kit Check in 2011, it combines RFID tracking with analytics and investigation workflows and says more than 3,000 US and Canadian hospitals use its products.

- **Founded:** 2011
- **Headquarters:** Alexandria, United States
- **Founders:** Kevin MacDonald (Co-founder and CEO), Tim Kress-Spatz (Co-founder)
- **Products:** KitCheck, ControlCheck, CostCheck, 340BCheck, ShortageCheck
- **Notable:** Reported over 250 hospital customers and USD 37.4 million raised by June 2016., Expanded through Medacist, Sectyr, and Protenus acquisitions., Reported more than 3,000 US and Canadian hospital customers in 2026.

## Products & services

- **KitCheck** — RFID medication tracking for kits, trays, and inventory; pairs scanning stations with cloud software.
- **ControlCheck** — Controlled-substance reconciliation, behavioral analytics, and investigation workflows.
- **CostCheck** — Drug purchasing analysis, alternative-product recommendations, and contract and invoice monitoring.
- **340BCheck** — Compliance workflows and transaction auditing for covered entities; redesigned in 2026.
- **ShortageCheck** — Drug shortage monitoring and coordinated inventory response.
- **PrivacyPro** — Patient-record access monitoring and privacy investigation workflows; derived from Protenus.
- **Prism Assistant** — In-app AI assistant launched in ControlCheck in May 2026 and PrivacyPro in October 2026.

## Achievements

- Reported over 250 hospital customers and USD 37.4 million raised by June 2016.
- Expanded through Medacist, Sectyr, and Protenus acquisitions.
- Reported more than 3,000 US and Canadian hospital customers in 2026.
- Sentara case material reports more than USD 3.45 million in purchasing savings in under two years.

## Latest updates

- **2026-10** — October 14: Prism Assistant launched in PrivacyPro; four early-adopter health systems reported one to two hours saved per case.
- **2026-10** — October 8: Diversion Trends Report analyzed more than 295 million controlled-substance transactions and highlighted the continuing importance of human reporting.
- **2026-05** — Prism Assistant launched within ControlCheck.
- **2026-04** — Redesigned 340BCheck launched; Pharma Logistics partnership formally announced.

## Links

- Website: https://bluesight.com/
- LinkedIn: https://www.linkedin.com/company/bluesight-inc/
- Twitter/X: https://twitter.com/kitcheck
- YouTube: https://www.youtube.com/channel/UCWxWprG7xq0ggZOUJEEnytw
- Instagram: https://www.instagram.com/kitcheck/
- Facebook: https://www.facebook.com/kitcheck/

---

Profile page: https://yespress.io/bluesight
Published by YesPress — https://yespress.io
Last updated: 2026-10-25